CurveBeam AI Past Earnings Performance
We're still processing the latest earnings report of this company
Past criteria checks 0/6
CurveBeam AI's earnings have been declining at an average annual rate of -303.3%, while the Medical Equipment industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 545.1% per year.
Key information
-303.3%
Earnings growth rate
-24.6%
EPS growth rate
| Medical Equipment Industry Growth | 5.8% |
| Revenue growth rate | 545.1% |
| Return on equity | -120.9% |
| Net Margin | -603.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How CurveBeam AI makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 9 | -57 | 26 | 1 |
| 30 Sep 23 | 9 | -54 | 23 | 1 |
| 30 Jun 23 | 8 | -51 | 20 | 1 |
| 31 Mar 23 | 5 | -33 | 16 | 0 |
| 31 Dec 22 | 1 | -14 | 12 | 0 |
| 30 Sep 22 | 1 | -11 | 10 | 0 |
| 30 Jun 22 | 0 | -9 | 7 | 0 |
| 30 Jun 21 | 1 | -3 | 3 | 0 |
Quality Earnings: CVB is currently unprofitable.
Growing Profit Margin: CVB is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if CVB's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare CVB's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CVB is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).
Return on Equity
High ROE: CVB has a negative Return on Equity (-120.89%), as it is currently unprofitable.